VeriMomtripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1은 임신 중 안전한가요?
No harmonised CLP reproductive classifications (ECHA Annex VI) or CIR/SCCS safety opinions listing reproductive hazard for these cosmetic peptides. Peer‑reviewed and regulatory sources for cosmetic peptides (e.g., oligopeptides/dipeptides/tripeptides used in topical products) do not report teratogenicity or reproductive toxicity; large peptide size and intended topical use make systemic reproductive hazard unlikely (sources: ECHA Annex VI — no harmonised H360/H361, CosIng/PubChem entries show cosmetic peptide use, no CIR/SCCS reproductive findings).
Related ingredients
Frequently asked questions
- tripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1은 임신 중 안전한가요?
- No harmonised CLP reproductive classifications (ECHA Annex VI) or CIR/SCCS safety opinions listing reproductive hazard for these cosmetic peptides. Peer‑reviewed and regulatory sources for cosmetic peptides (e.g., oligopeptides/dipeptides/tripeptides used in topical products) do not report teratogenicity or reproductive toxicity; large peptide size and intended topical use make systemic reproductive hazard unlikely (sources: ECHA Annex VI — no harmonised H360/H361, CosIng/PubChem entries show cosmetic peptide use, no CIR/SCCS reproductive findings).
- tripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1은 모유 수유 중 안전한가요?
- No data indicating reproductive or lactation hazards, no regulatory classifications for breastfeeding risk. Topical cosmetic peptides are large molecules with low dermal penetration in available literature and no evidence of transfer into breast milk or lactation-specific adverse effects in human studies or regulatory assessments (sources: CosIng, PubChem, absence of SCCS/CIR concerns).
- tripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1은 아기 피부에 안전한가요?
- No evidence of developmental or infant‑specific reproductive toxicity. Peptides used in cosmetics are high molecular weight and generally show negligible dermal absorption; therefore exposure to infants (0–3 yr) from typical topical cosmetic use is expected to be minimal and no infant‑specific hazard is documented. No harmonised CLP flags or published infant toxicity data were found (sources: CosIng, PubChem, PubMed literature absence).
- VeriMom은 tripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 tripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1을 100/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 tripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.